Yes, a white person can absolutely get sickle cell disease. While sickle cell disease (SCD) is far more common in people of African descent — affecting roughly 1 in 365 Black Americans — it also occurs in Caucasians, particularly those with Mediterranean, Middle Eastern, or South Asian ancestry. Estimates suggest that sickle cell disease affects approximately 1 in 10,000 to 1 in 40,000 white individuals in parts of Southern Europe, including Greece, Italy, and Turkey.
The misconception that sickle cell is exclusively a “Black disease” has real consequences. White patients with SCD are frequently diagnosed later, misdiagnosed, or dismissed in emergency rooms because clinicians simply aren’t looking for it. If you’re white and experiencing unexplained pain crises, chronic anemia, or recurrent infections, sickle cell disease deserves a spot on the differential — regardless of your skin color.
Why Is Sickle Cell Disease More Common in Some Ethnicities?
The answer comes down to malaria. The sickle cell gene mutation arose independently in several regions where malaria was historically endemic — sub-Saharan Africa, the Mediterranean basin, the Arabian Peninsula, and parts of India. Carrying one copy of the sickle cell gene (sickle cell trait) provides a survival advantage against Plasmodium falciparum malaria, which is why natural selection preserved the mutation in these populations over thousands of years.
This means the gene isn’t tied to race — it’s tied to geography and evolutionary pressure. A Greek farmer’s ancestors faced the same malarial selection pressures as a Nigerian farmer’s ancestors, which is why both populations carry the HbS gene today.
How Common Is Sickle Cell Trait in White Populations?
Sickle cell trait (carrying one copy of the HbS gene, typically without symptoms) varies significantly across white ethnic groups:
| Population | Estimated Sickle Cell Trait Prevalence |
|---|---|
| African Americans | ~8% (1 in 13) |
| Greek (certain regions) | 1–2% |
| Southern Italian / Sicilian | 1–3% |
| Turkish | 2–10% (varies by region) |
| Northern European (UK, Scandinavia) | <0.1% |
| Middle Eastern / Arabian Peninsula | 5–25% (varies widely) |
For a white person to develop sickle cell disease (not just trait), both parents must carry at least one copy of the HbS gene. This is uncommon but entirely possible — especially in Mediterranean families or in any family with mixed ancestry.
The Genetics: How a White Person Inherits Sickle Cell Disease
Sickle cell disease follows an autosomal recessive inheritance pattern. A single nucleotide change in the HBB gene (a glutamic acid-to-valine substitution at position 6) produces abnormal hemoglobin S (HbS). Here’s the breakdown:
- Two normal copies (HbAA): No disease, no trait
- One normal + one HbS copy (HbAS): Sickle cell trait — usually asymptomatic
- Two HbS copies (HbSS): Sickle cell disease (the most severe form)
- One HbS + one HbC or other variant: Compound heterozygous sickle cell disease (HbSC, HbS-beta thalassemia, etc.)
That last point is particularly relevant for white patients. In Mediterranean populations, beta-thalassemia mutations are common. A person who inherits one sickle cell gene and one beta-thalassemia gene develops HbS-beta thalassemia — a form of sickle cell disease that can range from mild to severe. This combination is actually one of the more common ways Caucasians end up with SCD.
Symptoms Look the Same Regardless of Race
The clinical presentation of sickle cell disease in white patients is essentially identical to that in Black patients. Key symptoms include:
- Vaso-occlusive (pain) crises: Sudden, severe pain in the chest, abdomen, joints, or bones lasting hours to days
- Chronic hemolytic anemia: Hemoglobin levels often running 6–9 g/dL
- Fatigue and jaundice from ongoing red blood cell destruction
- Frequent infections, particularly in childhood, due to splenic dysfunction
- Acute chest syndrome: A potentially life-threatening lung complication
- Stroke risk: Children with SCD have a 300-fold increased stroke risk compared to the general pediatric population
One clinical difference worth noting: some studies suggest that white patients with SCD may have slightly higher baseline hemoglobin levels and fewer pain episodes on average, possibly due to differences in co-inherited genetic modifiers like alpha-thalassemia. However, the disease is still serious and potentially life-threatening regardless of ethnicity.
Diagnosis: What Tests to Ask For
If you’re white and suspect you might carry the sickle cell gene — because of Mediterranean or Middle Eastern ancestry, unexplained anemia, or a family history — these are the tests to request:
- Hemoglobin electrophoresis: The gold-standard screening test that separates and identifies different hemoglobin types
- High-performance liquid chromatography (HPLC): Often used in newborn screening programs and highly accurate
- Complete blood count (CBC): Will show anemia and may reveal sickled cells on the peripheral smear
- Genetic testing: Can confirm the specific HBB gene mutation and identify compound heterozygous states like HbS-beta thalassemia
In the United States, all 50 states now include sickle cell disease in their newborn screening panels, which means white babies with SCD should theoretically be caught at birth. However, cases still slip through — particularly HbS-beta thalassemia variants that may produce borderline results on initial screening.
Treatment Options in 2024
Treatment for sickle cell disease has advanced dramatically in recent years:
- Hydroxyurea: Still the backbone of therapy. Increases fetal hemoglobin (HbF) levels, reducing sickling and pain crises by 40–50%
- Voxelotor (Oxbryta): Inhibits HbS polymerization, improving hemoglobin by ~1 g/dL on average
- Crizanlizumab (Adakveo): A monoclonal antibody targeting P-selectin that reduces vaso-occlusive crises
- L-glutamine (Endari): Reduces oxidative stress in sickle red blood cells
- Gene therapy: The FDA approved two gene therapies in December 2023 — exagamglogene autotemcel (Casgevy), the first CRISPR-based therapy, and lovotibeglogene autotemcel (Lyfgenia). Both offer potential functional cures
- Bone marrow transplant: The only established cure, with a success rate above 90% when a matched sibling donor is available
When to See a Doctor
You should seek evaluation if:
- You have Mediterranean, Middle Eastern, or South Asian ancestry and experience unexplained chronic anemia or recurrent pain episodes
- You’re planning a pregnancy and want to know your carrier status — especially if your partner also has ancestry from malaria-endemic regions
- Your child’s newborn screening showed any hemoglobin variant and you haven’t received follow-up testing
- You’ve been told you have “sickle cell trait” and want to understand the implications for your children
Ask your doctor specifically for hemoglobin electrophoresis — a standard CBC alone won’t detect sickle cell trait.
Frequently Asked Questions
How rare is sickle cell disease in white people?
It’s uncommon but not as rare as most people think. In Southern Europe (Greece, southern Italy, Turkey), sickle cell disease affects roughly 1 in 10,000 to 1 in 40,000 individuals. Among Northern Europeans with no Mediterranean ancestry, it’s extremely rare. In the U.S., the vast majority of the estimated 100,000 people living with SCD are Black, but several hundred white Americans are also affected.
Can two white parents have a child with sickle cell disease?
Yes. If both parents carry sickle cell trait (HbAS) — which they may not know about — there’s a 25% chance with each pregnancy that their child will have sickle cell disease. This is most likely in families with Greek, Italian, Turkish, or Middle Eastern heritage.
Is sickle cell disease less severe in white patients?
Not necessarily. Some studies suggest slightly milder courses in certain white patients due to co-inherited genetic modifiers, but the disease can be just as severe and life-threatening. The bigger danger for white patients is delayed diagnosis because clinicians may not consider SCD in a non-Black patient.
Should white people get tested for sickle cell trait?
If you have ancestry from the Mediterranean, Middle East, or Indian subcontinent and are planning a family, pre-conception carrier screening is a smart idea. In the U.S., newborn screening catches most cases at birth, but knowing your carrier status before pregnancy allows for informed family planning.
Is sickle cell trait the same as sickle cell disease?
No. Sickle cell trait (HbAS) means you carry one copy of the gene and generally have no symptoms under normal conditions. Sickle cell disease (HbSS, HbSC, or HbS-beta thalassemia) means you have two abnormal hemoglobin genes and will experience clinical disease. Trait carriers can, however, pass the gene to their children.
